Meridiem Capital Partners LP Exact Sciences Corp Transaction History
Meridiem Capital Partners LP
- $1.14 Trillion
- Q4 2024
A detailed history of Meridiem Capital Partners LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Meridiem Capital Partners LP holds 202,139 shares of EXAS stock, worth $10 Million. This represents 1.0% of its overall portfolio holdings.
Number of Shares
202,139Holding current value
$10 Million% of portfolio
1.0%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
671Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$870 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$845 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$599 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$598 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$309 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.78B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...